NASDAQ: MRLNMerlin Inc Stock
$3.31-0.23 (-6.5%)
Updated Aug 18, 2026
MRLN Price
$3.31
Fair Value Price
$0.02
Market Cap
$334.53M
52 Week Low
$3.17
52 Week High
$17.00
P/E
-0.04x
P/B
-3.35x
P/S
48.34x
PEG
N/A
Dividend Yield
N/A
Revenue
$10.75M
Earnings
-$228.35M
Gross Margin
0.6%
Operating Margin
-2,095.1%
Profit Margin
-5,997.5%
Debt to Equity
-1.45
Operating Cash Flow
-$110M
Beta
0.48
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MRLN Overview
Merlin, Inc. is a US-based developer of cost-effective, takeoff-to-touchdown autonomy for both legacy and next-generation airborne systems. Its aircraft-agnostic, AI-powered software is purpose-built for military and civil programs and is powering an expanding range of missions and aircraft, proven through numerous autonomous flights from test facilities worldwide. The company works with military customers to address national security challenges through safe and reliable autonomy.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MRLN's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -12.86% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MRLN news, forecast changes, insider trades & much more!
MRLN News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MRLN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MRLN ($3.31) is overvalued by 15,781.28% relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MRLN ($3.31) is not significantly undervalued (15,781.28%) relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MRLN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MRLN due diligence checks available for Premium users.
Valuation
MRLN fair value
Fair Value of MRLN stock based on Discounted Cash Flow (DCF)
Price
$3.31
Fair Value
$0.02
Overvalued by
15,781.28%
MRLN ($3.31) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MRLN ($3.31) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MRLN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MRLN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.04x
Industry
19.27x
Market
15.03x
MRLN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-3.35x
Industry
10.41x
MRLN's financial health
Profit margin
Revenue
$2.2M
Net Income
-$58.4M
Profit Margin
-5,811.3%
MRLN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MRLN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$207.0M
Liabilities
$144.4M
Debt to equity
-1.45
MRLN's short-term assets ($191.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRLN's short-term assets ($191.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRLN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MRLN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$27.3M
Investing
-$1.7M
Financing
$89.7M
MRLN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MRLN vs Defense Stocks
Merlin Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.